SBIR/STTR Research Award

Reducing time, sample handling, and staff requirements for complement activation monitoring in clinical trials

Award identifier eb1587b252ace9afcc6dab46ca2af1982853485a8a8dd10e56e271c0a1d80eabAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$218,241

Program and phase

SBIR · Phase I

Award year

2016

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
KYPHA INC.
Proposal award date
2016-06-10
Contract end date
2017-05-31
UEI
Not reported
Solicitation number
PA13-052
Topic code
400

Research abstract

DESCRIPTION provided by applicant Despite overwhelming evidence that the complement system is involved in kidney and cardiovascular outcomes stringent technical requirements limit its inclusion in clinical trials and diagnostics Current protocols require careful sample collectin immediate freezing and shipping to only a few specialized labs As a result while complement system proteins C and C are routinely measured in autoimmune disease clinics proteolytically activated split products known to mediate active inflammatory and autoimmune processes are rarely assessed Kypha Inc is developing an integrated point of care POC platform to make reliable complement data more accessible to clinical trials and diagnostic applications These efforts are timely due to recent therapeutic development focused on anti inflammatory strategies including complement inhibition for extracorporeal therapies such as hemodialysis autoimmunity transplant rejection and other conditions Milestones in this Phase I proposal will demonstrate the feasibility of using advanced multiplex quantitative lateral flow assays in the point of care as a solution that decreases the resources required to measure complement activation and inflammation in clinical trials paving the way for their full utility inthe diagnosis and management of acute and chronic renal and vascular inflammatory diseases PUBLIC HEALTH RELEVANCE Complement activation is a known mediator of inflammatory renal and vascular pathophysiology However protein instability in vitro requires stringent sample handling and laboratory requirements that limit the inclusion of complement biomarkers in clinical trials Rapid simple and comprehensive complement assays will make reliable complement data more accessible This project will establish point of care biochemical data collection as a feasible approach for improving anti inflammatory clinical trials in hemodialysis and other renal conditions

Technology keywords

Not reported

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.